Format

Send to

Choose Destination
Rev Calid Asist. 2012 Mar-Apr;27(2):72-7. doi: 10.1016/j.cali.2011.09.008. Epub 2011 Dec 3.

[Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus].

[Article in Spanish]

Author information

1
Centro de Salud de Rentería-Beraun, Comarca Ekialde de Guipúzcoa, Osakidetza, Servicio Vasco de Salud, Rentería-Beraun, Guipúzcoa, España. Luisa.gutierrezangulo@osakidetza.net

Abstract

OBJECTIVE:

1) To determine gender differences regarding therapeutic adherence in patients with arterial hypertension and type 2 diabetes mellitus. 2) To detect differences in terms of age. 3) To determine existing relationships in patient compliance levels between Morisky-Green's test, Batalla's test and the pill count expressed as a percentage of compliance.

METHOD:

Descriptive, transversal study, carried out for a period of 7 months in the Primary Health Care, Health Centre in Rentería-Beraun (Guipúzcoa), Basque Health Service (Osakidetza), with an incidental sample of 100 patients diagnosed with hypertension and type 2 diabetes mellitus and receiving oral treatment. Principal variables: age, gender. Conditioning variables: years of evolution of each pathology, number of prescribed medicines, time lapse of prescription collection, Morisky-Green's test, Batalla's test and pill count.

RESULTS:

The statistical analysis yielded similar compliance for men and women, and for different age groups (Morisky-Green and pill count). Approximately 50% of the patients had adequate compliance according to at least one of the 3 tests. A greater relationship was found between Morisky-Green's test and the pill count method, and medication adherence improved when knowledge of the disease increased, and when the number of prescribed pills became smaller.

CONCLUSIONS:

Adherence varies according to the evaluation tool used, non-adherence is high and knowledge of the disease helps compliance. This suggests the convenience of systematically reviewing treatments and supplying more information to patients.

PMID:
22138203
DOI:
10.1016/j.cali.2011.09.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center